Literature DB >> 8620493

Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis.

D Gallahan1, C Jhappan, G Robinson, L Hennighausen, R Sharp, E Kordon, R Callahan, G Merlino, G H Smith.   

Abstract

Insertional mutation of the Int3 gene, a member of the Notch gene family, is frequently associated with primary mouse mammary tumors induced by the mouse mammary tumor virus (MMTV). A major consequence of these mutations is the production of a shortened 2.4-kb tumor specific Int3 RNA transcript that encodes the entire intracellular domain of the Int3 protein. Previous studies have demonstrated that mammary gland development and function was severely impaired in transgenic mice expressing the truncated Int3 gene product from the MMTV viral promoter. Both mammary ductal growth and secretory lobule development were curtailed in these mice. These results were attributed to a gain of function modification of the Int3 gene, which led to a restriction of cell fate selection in the affected mammary epithelial cells. To confirm and extend these findings, truncated Int3 was expressed from the whey acidic protein (WAP) promoter, the activity of which, unlike that of the MMTV long terminal repeat, is restricted to the secretory mammary epithelial population. In transgenic mice carrying the WAP/Int3 construct, mammary ductal growth was unaffected in virgin females, but growth and differentiation of secretory lobules during gestation was profoundly inhibited. Coincidental with the block in lobular secretory differentiation, mammary dysplasia and tumorigenesis occurred in all breeding females by 25 weeks of age. In nonbreeding WAP/Int3 females, mammary tumor incidence also reached 100%, but only after 70 weeks. The WAP/Int3 mammary tumors were highly malignant, and most tumor-bearing females, irrespective of breeding history, developed metastatic lung lesions. These results suggest that WAP promotor-targeted Int3 function is associated with mammary secretory cell differentiation and maintenance in this transgenic model. Consistent with the conclusion that WAP-driven truncated Int3 expression influenced only lobular differentiation and not ductal growth and extension during mammary gland development, transplants of WAP/Int3 gland into nontransgenic mammary fat pads produced complete mammary ductal outgrowths in virgin FVB/N mice but failed to develop secretory lobules when the females were impregnated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8620493

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  85 in total

Review 1.  Notch signaling in mammary development and oncogenesis.

Authors:  Robert Callahan; Sean E Egan
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-04       Impact factor: 2.673

Review 2.  Paradigms of notch signaling in mammals.

Authors:  Alexis Dumortier; Anne Wilson; H Robson MacDonald; Freddy Radtke
Journal:  Int J Hematol       Date:  2005-11       Impact factor: 2.490

Review 3.  Notch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentials.

Authors:  Wen Shi; Adrian L Harris
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-01       Impact factor: 2.673

4.  Glucocorticoid and growth factor synergism requirement for Notch4 chromatin domain activation.

Authors:  Jing Wu; Emery H Bresnick
Journal:  Mol Cell Biol       Date:  2007-01-12       Impact factor: 4.272

Review 5.  Endocytic proteins in the regulation of nuclear signaling, transcription and tumorigenesis.

Authors:  Beata Pyrzynska; Iwona Pilecka; Marta Miaczynska
Journal:  Mol Oncol       Date:  2009-06-11       Impact factor: 6.603

6.  Dose-dependent induction of distinct phenotypic responses to Notch pathway activation in mammary epithelial cells.

Authors:  Marco Mazzone; Laura M Selfors; John Albeck; Michael Overholtzer; Sanja Sale; Danielle L Carroll; Darshan Pandya; Yiling Lu; Gordon B Mills; Jon C Aster; Spyros Artavanis-Tsakonas; Joan S Brugge
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-01       Impact factor: 11.205

Review 7.  Notch inhibitors for cancer treatment.

Authors:  Ingrid Espinoza; Lucio Miele
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

8.  Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells.

Authors:  L Hao; P Rizzo; C Osipo; A Pannuti; D Wyatt; L W-K Cheung; G Sonenshein; B A Osborne; L Miele
Journal:  Oncogene       Date:  2009-10-19       Impact factor: 9.867

Review 9.  Genetically engineered mouse models of mammary intraepithelial neoplasia.

Authors:  R D Cardiff; D Moghanaki; R A Jensen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

Review 10.  The preneoplastic phenotype in murine mammary tumorigenesis.

Authors:  D Medina
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.